Podcasts about opioids

SPONSORS: 1) MARS MEN: For a limited time, our listeners get 50% off FOR LIFE, Free Shipping, AND 3 Free Gifts at Mars Men at https://Mengotomars.com JOIN PATREON FOR EARLY UNCENSORED EPISODE RELEASES: https://www.patreon.com/JulianDorey CLIPPERS DISCORD: https://discord.gg/8QmWEKJ3BT (***TIMESTAMPS in description below) ~ Ben Westhoff is an investigative journalist and one of the most respected experts on the fentanyl crisis in America. His 2019 book, Fentanyl, Inc. exposed the entire fentanyl market problem to the mainstream FOLLOW BEN: IG: https://www.instagram.com/ben.westhoff/?hl=en BOOK: https://a.co/d/03cARvfi DOC: https://www.antagonistfilm.com/ FOLLOW JULIAN DOREY YT: https://www.instagram.com/julianddorey/ X: https://x.com/juliandorey JULIAN YT CHANNELS - SUBSCRIBE to Julian Dorey Clips YT: https://www.youtube.com/@juliandoreyclips - SUBSCRIBE to Julian Dorey Daily YT: https://www.youtube.com/@JulianDoreyDaily - SUBSCRIBE to Best of JDP: https://www.youtube.com/@bestofJDP ****TIMESTAMPS**** 00:00 - Fentanyl Inc., Rave Deaths, China Labs 08:50 - Undercover in China, Suspicious Lab Visit, CCP Rebates 22:51 - Capitol Hill Testimony, Fentanyl Analogs, India Precursors 29:55 - Naltrexone, Vivitrol, Addiction Treatment, Methadone Business 39:49 - Psychedelics, Capitalism, Naltrexone Documentary, Dark Web Dealers 49:29 - Fent-Laced Coke, Antagonist, Percy Menzies, Vivitrol Trials 58:18 - AA, Opioids, Alcohol, Compulsive Behaviors, Naltrexone Critics 01:10:32 - Addictive Personalities, Purdue Pharma, Suboxone Pill Mills 01:11:10 - Standard American Diet, Veganism, Factory Farming, New Holocaust 01:23:43 - Factory Farming, Forks Over Knives, Subsidies, Protein Obsession 01:39:29 - McDonald's Subsidies, Vegan Costs, Grocery Prices, Sports Gambling 01:48:14 - Silk Road, Bitcoin, Gold, Dark Web Dealers 01:58:45 - Online Drug Markets, Snowden, FISA, Hip Hop Journalism 02:08:08 - Eazy-E, Cancel Culture, Substack, NuWaubians, MF DOOM 02:21:05 - Afrika Bambaataa, Music Journalism, Kanye, Narratives 02:29:01 - Streaming, West Coast Hip Hop, Jimmy Iovine, Tupac 02:40:53 - Interscope Records Scandals CREDITS: - Host, Editor & Producer: Julian Dorey - COO, Producer & Editor: Alessi Allaman - https://www.youtube.com/@UCyLKzv5fKxGmVQg3cMJJzyQ - In-Studio Producer: Joey Deef - https://www.instagram.com/joeydeef/ Julian Dorey Podcast Episode 434 - Ben Westhoff Learn more about your ad choices. Visit podcastchoices.com/adchoices

The provided transcript documents a Newtown Township Board of Supervisors meeting where officials debated the allocation of $133,000 in opioid settlement funds. The township solicitor proposed a Memorandum of Understanding to transfer these funds to Bucks County, arguing that the township lacks the necessary infrastructure to manage permitted drug treatment programs. While some board members supported the move to ensure the continuation of a county-funded co-responder program, others expressed concerns that the township would lose local control over the money. Public comment suggested keeping the funds local to support drug education within the Council Rock School District, highlighting a perceived lack of transparency regarding eligible uses. Opponents of the transfer argued that the township might be marginalized by the county due to its affluence and questioned why local alternatives hadn't been fully explored. Facing a fast-approaching deadline to obligate the funds, the board ultimately voted to table the motion to allow for further research into regional options.

In this episode of The Visible Voices Podcast, I sit down with Dr. Scott Weiner, emergency physician, associate professor at Harvard Medical School, and founder of system-wide substance use disorder programming.  Dr. Weiner shares the patient cases that set his life's work in motion, including a fatal overdose on Boston Common that changed how he understood both medicine and advocacy.  Scott addresses the troubling gap in opioid education in American schools, the promise of wearable technology for monitoring patients in recovery, and the real reasons overdose deaths are finally starting to decline. Opioid use disorder is not a moral failure — it is a public health crisis. ▶ Subscribe on YouTube @resaelewissmd — new Visible Voices episodes Wednesdays.

Have you ever been told that the thing you need to get better doesn't exist on the NHS but quietly, it does?This week I'm joined by Dr. Simon Erridge, medical doctor, UCL researcher, and one of the UK's leading voices in medical cannabis. Simon has a way of cutting through the stigma and the noise and what he shares isn't about getting high. It's about patients who've tried everything, suffered for years, and finally found relief.What we explore together:What medical cannabis actually is  and why it's nothing like what you probably picture when you hear the word cannabisWhy the UK is one of the highest opioid-prescribing countries in the world, and what that tells us about how we treat chronic painWhat's actually happening in the brain with PTSD and how medical cannabis can help decouple the trauma from the memory itselfThe shocking contamination rates in illicit cannabis, and why the black market route puts people at real riskWho shouldn't use medical cannabis, and the conditions where it's not appropriateThe full range of conditions being treated right now: from migraines, Crohn's disease and MS to anxiety, depression, OCD and cancer-related symptomsIf you or someone you love has been living with chronic pain, PTSD, endometriosis, or any condition that feels like it has no solution this one is for you.Love, Sarah Ann

Mehul V. Raval, MD, MS, shares how an enhanced recovery protocol improved postsurgical outcomes for children.

CMS continues to pull on the levers it has at its disposal to rein in national healthcare spend, including rulemaking around Medicare Advantage. In April, CMS announced the final rate for MA plans for CY2027, after a controversial proposed rule generated animated pushback — and a fair bit of panic — among payers. In this episode, host Abby Burns speaks with Alex Balmes, Vice President of Actuarial Services at Optum, to unpack what did — and didn't — end up in the final rate announcement, and what that signals for the future of the Medicare Advantage program. Together, they explore the components of the final rate that are most important for payers and providers to pay attention to, respectively, and why. Also in the 2027 final announcement, but not discussed in this episode: four measures are being added or updated in Star ratings calculations (Colorectal Cancer Screening; Care for Older Adults – Functional Status Assessment; Concurrent Use of Opioids and Benzodiazepines (COB); Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH)) and three are being removed (Care for Older Adults – Pain Assessment, Medication Reconciliation Post-Discharge, Medication Therapy Management (MTM) Program Completion Rate for Comprehensive Medication Review (CMR)) We're here to help: Read the 2027 CMS Announcement | 2027 | CMS Episode | 286: A Medicare Advantage reset — and what comes next Ready-to-Use Slides | Medicare Advantage market outlook Stay informed | Healthcare policy updates Tool | Policy Scenario Impact Calculator Connect with an Optum Advisory expert | Optum Learn more about Advisory Board's 2026 summit series. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

The damage caused by alcohol costs Americans billions of dollars, and it largely goes unnoticed. Isabella Cueto, chronic disease reporter for Stat, joins host Krys Boyd to discuss the harms of alcohol from elevated cancer risk to liver damage to its impact on violent crime and why public health officials don't seem to have a cohesive strategy to combat its very real consequences. Her series, written with Lev Facher, is “The Deadliest Drug.” Learn about your ad choices: dovetail.prx.org/ad-choices

Scott Kaufman, the Community Initiatives Supervisor, and Jarrett Burton, Coordinator of the Dupage Recovery Oriented System of Care (ROSC), speak with Lisa to discuss the launch of the Dupage Naloxone Program. They highlight the initiative designed to distribute and make available Opioid-related overdose medication to schools, libraries, emergency services, and residents of Illinois.

War is erupting again in the Middle East tonight. For the first time since a fragile ceasefire was enacted in April, Iran launched a direct attack on Israel. It comes in response to Israel's continued strikes on Lebanon's capital. Israel has vowed retaliation. But U.S. President Donald Trump still maintains that a peace deal is close to fruition.Also: Opioid overdoses are skyrocketing in Winnipeg. A CBC data analysis shows the Winnipeg Fire Paramedic Service has responded to more than 2-thousand opioid calls so far this year. Manitoba's government has announced one million dollard to address the toxic drug crisis. You'll hear more about what the province is up against. And: The FIFA World Cup will begin this week. As the event draws more attention to soccer, Canadian officials think it's a good time to pitch a big project to secure long term support for this country's players. Plus: Canada's new Governor General, Undocumented farmworkers fear deportation in California, and more

June 5, 2026 - We examine the top line spending on combatting the opioid epidemic in the recently adopted state budget with Rob Kent, former general counsel at the state Office of Addiction Services and Supports. We also consider regulatory reform to improve the state's capacity.

We are excited to have Joyce Fetrow, project director of the North Michigan Opioid Response Consortium, join us on today's episode of Rural Health Today. Opioid use continues to be prevalent in rural communities, especially those lacking the resources to address it with sustainable solutions. Joyce is here to share her perspective as a leader in the field of opioid response. We'll talk about effective programming, prevention methods, and of course, what it all has to do with rural health.  Follow Rural Health Today on social media! https://x.com/RuralHealthPod https://www.youtube.com/@ruralhealthtoday7665  Follow Hillsdale Hospital on social media! https://www.facebook.com/hillsdalehospital/ https://www.twitter.com/hillsdalehosp/ https://www.linkedin.com/company/hillsdale-community-health-center/ https://www.instagram.com/hillsdalehospital/  Follow our guest! https://www.linkedin.com/in/joyce-fetrow-cprm-cprm-m-chw-87473914b/ https://www.linkedin.com/company/michigan-center-for-rural-health/

Both animals and people can overdose on opioids, like fentanyl or heroine. Dogs —…

Both animals and people can overdose on opioids, like fentanyl or heroine. Dogs — especially those on police K9 units — are the animals most at risk, since they explore...

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl probe the facts beneath healthcare's biggest headlines. Today's show examines the accelerating progress of generative AI, the political turmoil inside America's leading health agencies and the infectious disease threats testing the nation's public health readiness. The conversation opens with a listener question about how close generative AI is to matching clinicians. Dr. Pearl explains that the technology is advancing faster than he predicted in ChatGPT, MD, with recent research showing an OpenAI model outperforming experienced physicians on emergency room triage and management in text-based clinical cases. He cautions that medicine is more complicated than written scenarios but argues that the trajectory is clear: before today's incoming medical students finish training, generative AI tools are likely to be used in emergency rooms across the country From there, the episode turns to the resignation of former FDA commissioner and Dr. Marty Makary, a two-time Fixing Healthcare guest. Pearl describes Makary as a respected clinician and patient-safety expert who found himself caught between scientific rigor, political pressure, industry opposition and public health critics. His departure, along with other leadership upheaval at FDA, CDC, NIH and HHS, raises a larger concern about whether America's once-trusted scientific agencies can regain their independence and credibility. Here are the other major storylines from episode 107: RFK Jr. removes preventive-care leaders. Pearl criticizes the firing of two respected co-chairs of the U.S. Preventive Services Task Force, warning that prevention policy may be pushed away from scientific evidence. The surgeon general nomination moving toward confirmation. Nicole Safier appears more confirmable than Dr. Casey Means because her vaccine views are closer to the scientific mainstream. A hantavirus outbreak raises public health concerns. A cruise ship outbreak involving the Andes virus appears to have spread person-to-person, causing at least 13 cases, several severe illnesses and three deaths. The U.S. remains vulnerable to fast-moving outbreaks. Pearl says the slow federal response to hantavirus shows how weakened public health capacity could become dangerous if a highly lethal virus were also easily transmissible. Tick bites are rising sharply. ER visits related to tick bites have climbed well above typical levels, driven in part by warmer temperatures and the spread of deer ticks into the Midwest and South. Ebola exposes the cost of global health cuts. A new Ebola strain in the Democratic Republic of Congo has no vaccine or effective treatment, and the outbreak was recognized only after spreading for weeks. USAID and WHO cuts increase risk to Americans. Pearl argues that reducing global public health support does not put “America first” because viruses ignore national borders. Patients should be more concerned when doctors avoid AI entirely. Pearl says he would worry more about clinicians who refuse to use reliable generative AI tools than those who consult them regularly. Opioid overdose deaths are falling but remain devastating. New CDC data show overdose deaths down for the third straight year, but annual fatalities still total roughly 70,000, with overdoses remaining the leading cause of death among adults ages 18 to 44. Vaccine safety data are being suppressed. Pearl closes by describing blocked FDA and CDC research showing COVID and shingles vaccines to be safe and effective, warning that political censorship undermines trust and harms patients. Tune in for more fact-based analysis and practical perspective on the healthcare policies, technologies and trends shaping medicine today. * * * Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post MTT #107: How politics is weakening America's public health defenses appeared first on Fixing Healthcare.

Episode SummaryNancy Deyo is a former Silicon Valley CEO, Stanford Distinguished Careers Institute Fellow, and author of the forthcoming memoir Perilous Ascent. After a medical crisis on Mount Kilimanjaro, Nancy entered a fifteen-year journey through misdiagnosis, chronic pain, opioid dependence, and identity collapse.In this episode of Stories from Real Life, Nancy shares how the strategies that once defined her success—discipline, endurance, ambition, and pushing through—eventually had to be reexamined. Her story is not about a simple cure or a clean comeback. It is about learning to live differently when life no longer responds to effort in the same way.This conversation explores chronic pain, medical uncertainty, high-performance culture, shame, adaptation, and the deeper meaning of resilience.In This Episode, We Discuss* The medical crisis Nancy experienced on Mount Kilimanjaro* How chronic pain reshaped her identity and daily life* The long road through misdiagnosis and medical uncertainty* Opioid dependence in the context of chronic pain* The emotional cost of high-performance culture* Why “pushing through” can sometimes become harmful* Attending graduate school while unable to sit* Rebuilding a meaningful life without pretending everything is fixed* Her forthcoming memoir, Perilous Ascent* A more honest definition of resilienceMemorable ThemesOne of the most powerful ideas in this conversation is that resilience does not always mean pushing harder. Sometimes resilience means recognizing limits, grieving the life that changed, and adapting with honesty rather than force.Nancy's story will resonate with anyone living with chronic illness, navigating burnout, facing medical uncertainty, caregiving for someone in pain, or rebuilding after a major life disruption.About Nancy DeyoNancy Deyo is a former Silicon Valley CEO and Stanford Distinguished Careers Institute Fellow. Her forthcoming memoir, Perilous Ascent, reflects on a fifteen-year journey through chronic pain, misdiagnosis, opioid dependence, and personal transformation after a medical crisis on Mount Kilimanjaro.Through her writing and speaking, Nancy offers a candid look at what it means to live inside pain, question old definitions of strength, and find a new way forward.Connect with NancyRead Nancy's Substack: Life Inside Pain with Nancy DeyoMedia Well Done, LLC Get full access to Melvin E. Edwards at storiesfromreallife.substack.com/subscribe

A retrospective comparison of two state-funded smartphone-based contingency management programs with different incentives  Drug and Alcohol Dependence This retrospective study compared outcomes for patients with stimulant use disorder enrolled in a smartphone-based contingency management program based on the amount of total incentives possible, either $75 (“low-value”) or $599 (“moderate-value”). The low-value program was based in New Jersey, funded through SAMHSA (which limited reimbursement to $75/patient at the time of implementation, which has since been increased), and rewarded completing drug testing, attending counseling visits, and completing CBT modules rather than abstinence over 16 weeks. The moderate-value program was funded by West Virginia's Medicaid managed care organizations, lasted up to 26 weeks, and largely rewarded negative drug screening results, with additional rewards for counseling and CBT modules. Patients in the moderate-value program submitted significantly higher rates of negative substance tests (36%, with an average of 3.2 negative tests) compared to those in the low-value group (24.7%, with an average of 24.8 negative tests).   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

This week: Embarrassing drunken antics, gig dramas, perfect pitch, heapmaxxing, dude rooms, McCann's wrestling events, stranger encounters, Action Bronson at Katz Deli, analogue banking, tour shows review, Philly cheesesteaks, Miles Davis autobiography, Opioids, Comedy Cellar anxiety, slip & slides, throat lumps, twisted yoga & much more!Sign up to Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for access to exclusive episodes out every Thursday & our brand new merch.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/TheBombSquadPod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SSE ARENA '26 Tickets.⁠⁠⁠⁠⁠⁠⁠MERCH: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bombsquadpod.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow @TheBombSquadPod on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Hosted by:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Colin Geddis⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ &⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aaron McCann⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Produced & Edited by:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Niall Fegan⁠

Today we're bringing you the second part of the latest Sea Change episode, Losing Paradise.As Louisiana's coastal wetlands are claimed by the rising Gulf, fishermen and oil companies disagree over who has the right to the drowned land. Oil companies say they still pay taxes on the drowned property and have a right to keep off trespassers. Meanwhile fishermen say these are public navigable waters.Attempts to pass legislation that would bring clarity have failed, so host Carlyle Calhoun brings us to another battlefront - the courthouse.Billions from opioid settlements are flowing to local governments to help communities devastated by addiction.In Louisiana, one of the hardest-hit areas — Jefferson Parish — is set to receive tens of millions of dollars.But as the Gulf States Newsroom's Drew Hawkins and Verite News' Katie Jane Fernelius report, the parish has spent little of it so far.___Today's episode of Louisiana Considered was hosted by Alana Schreiber. Our managing producer is Alana Schrieber. We get production and technical support from Garrett Pittman, Adam Vos and Aubry Procell. You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, Google Play and wherever you get your podcasts. Louisiana Considered wants to hear from you! Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

Send us Fan MailOne infant is diagnosed with neonatal opioid withdrawal syndrome every 27 minutes, and rates are rising. In this episode of Journal Club, Ben and Daphna review the Optimized NOW randomized clinical trial, a landmark multicenter study published in JAMA. The trial compared symptom-based dosing,  a single opioid dose given when a withdrawal threshold is met against the traditional scheduled opioid taper in infants managed with Eat Sleep Console. The results are striking: symptom-based dosing reduced time to medical readiness for discharge by nearly two and a half days, and 65% of pharmacologically treated infants avoided scheduled opioid dosing entirely. Could this be the evidence-based approach that finally reshapes how we treat NOWS pharmacologically?----Symptom-Based Dosing for Neonatal Opioid Withdrawal: The OPTimize NOW Randomized Clinical Trial. Devlin LA et al HEAL Evaluation of Limited Pharmacotherapies for Neonatal Opioid Withdrawal Syndrome (HELP for NOWS) Consortium.JAMA. 2026 Apr 25:e265782. doi: 10.1001/jama.2026.5782. Online ahead of print. PMID: 42033722Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Mr. and Mrs. Weedman are back with another packed episode of the Weedman 420 Chronicles Podcast, breaking down the latest cannabis news, marijuana research, legalization updates, and industry headlines.This week, they discuss new studies on CBD's anti-cancer potential for dogs, medical marijuana helping pain patients reduce opioid use, psychosis risks linked to cannabis and tobacco, and the dangers of cannabis bud rot.They also cover major cannabis political and business news, including states that could legalize marijuana in 2026, medical marijuana expansion in Georgia and Iowa, New York's booming legal market, veterans gaining access to cannabis recommendations through the VA, and shifting federal marijuana policies.Plus, international cannabis headlines from Colombia, France, the UK, Jamaica, and beyond. As always, expect laughs, stoner commentary, smoke seshes, random tangents, and a few wild stories along the way as Mr. and Mrs. Weedman continue their mission to #StompTheStigma and #FreeThePlant.

  Purpose of the episode: Jeff Krajnak, a combat veteran, shares how medical cannabis helped him reduce opioid dependency and how THC metabolite laws led to criminal charges despite no impairment. Military service with the Navy Seabees and SEAL teams in Iraq and Afghanistan left Jeff with severe PTSD, fibromyalgia, and ankylosing spondylitis, resulting in a medical discharge in December 2013. Post-discharge, Jeff was consuming 11 opioid and psychiatric pills daily, drinking a bottle of vodka a day, and described himself as detached, suicidal, and hospitalized in a psych ward for eight days. Switching to medical cannabis — an indica strain for sleep and a CBD cream for pain — allowed Jeff to reduce from 11 pills to just one, and eventually quit opioids entirely. A 2017 car accident occurred when another driver ran a red light; Jeff and his son were uninjured, he cooperated with police, passed three field sobriety tests, and showed no signs of impairment. Despite every officer on scene testifying he was not impaired, Jeff was arrested 32 days later by a SWAT team due to THC metabolites in his blood — 4 nanograms active, 40 nanograms metabolite — exceeding Nevada's 2-nanogram legal limit. Charges included two felony B counts — felony DUI resulting in death and felony child neglect — carrying a potential 16–20 year prison sentence. Jeff accepted an Alford plea to felony reckless driving and misdemeanor DUI; the judge acknowledged he was not impaired but stated the law left her no choice. Probation terms banned cannabis use, forcing Jeff back onto 22 pills daily — highlighting the legal contradiction that allows high-dose opioid use while prohibiting medical cannabis. Nevada's 2-nanogram THC limit dates to 1999 and is based on a 1986–87 study measuring residual THC in reckless drivers' urine — not impairment — making it scientifically unsound. THC can remain in blood for weeks in chronic users, and up to 90 days depending on testing method and consumption type, meaning the legal limit bears no relationship to actual impairment. Other states apply higher or more flexible standards — California, Washington, and Colorado allow 5 nanograms with rebuttal options, and Michigan does not prosecute medical patients — contrasting sharply with Nevada's near-zero-tolerance approach. Jeff advocates for impairment-based DUI laws rather than residual THC thresholds, arguing that trained Drug Recognition Experts can assess actual impairment without relying on metabolite levels. As president of the Coalition for Patient Rights, Jeff is pushing for federal cannabis de-scheduling — arguing Schedule 3 is insufficient — and working with NORML, MPP, and other organizations to advance legislative reform. Visit our website: CannabisHealthRadio.comDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Health Talks, we explore the complexities of providing high-quality, compassionate care for pregnant patients with Opioid Use Disorder (OUD). Featuring Dr. Alexis Braverman, a board-certified OBGYN at UI Health, the conversation dives into the practical application of the "5 Ps" screening tool and the clinical necessity of moving beyond traditional silos toward a fully integrated care model. We address the understandable fear surrounding DCFS involvement—and discuss evidence-based strategies to build patient rapport while navigating mandated reporting requirements. We offer actionable insights on how integrated care leads to measurably better outcomes for families in recovery.

Arizona O'Neill is a Montreal-based writer and illustrator whose work has appeared in numerous magazines and outlets. In her debut graphic novel Opioids and Organs, she takes a deep dive into the history and ethics of organ donation and transplantation. Arizona tells Tom Power about how her father's death and subsequent organ donation a decade ago led her down the path to making this book. She also discusses the creative influence of both her parents and how the process of creating Opioids and Organs helped her process her grief and anger.

Virginia recorded one of the steepest declines in overdose deaths nationwide over the past year. But spending reductions in Medicaid, one of the largest payers for addiction and mental health treatment in the U.S., could significantly disrupt substance use treatment programs nationwide.

Republican plans for Oklahomans to change Medicaid expansion falls short at the Capitol.Congress considers year-round sales of ethanol to help ease the burden at the pumps.The Cherokee Nation is using opioid settlement money to help people in recovery.You can find the KOSU Daily wherever you get your podcasts, you can also subscribe, rate us and leave a comment.You can keep up to date on all the latest news throughout the day at KOSU.org and make sure to follow us on Facebook, Tik Tok and Instagram at KOSU Radio.This is The KOSU Daily, Oklahoma news, every weekday.

The Cherokee Nation is integrating culture into new treatment center built with opioid settlement funds.

Best practices for hospital-based initiation of medications for opioid use disorder: A consensus statement JAMA Network Open This survey study used a 2-round Delphi process to develop expert consensus on best practices for hospital-based MOUD initiation for patients with OUD, with a goal to provide guidance on changing inpatient addiction treatment in response to increased synthetic opioids in the unregulated drug supply. A total of 42 expert clinicians participated; clinicians were considered a national expert if they had cared for at least 100 hospitalized patients with OUD in the last two years. There was consensus that buprenorphine and methadone initiation in the hospital setting were appropriate, with less support for hospital-based naltrexone initiation. Consensus was also reached to support rapid methadone initiation; high- and low-dose buprenorphine initiation; and provision of non-MOUD full agonist opioids for treatment of opioid withdrawal during methadone initiation, as a bridge to buprenorphine initiation, and for those declining MOUD.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM  

The A2 protein variant was identified back in the 60s as a genetic difference among cattle. Recent consumer interest has driven a demand for A2/A2 milk, resulting in increased prevalence in the dairy industry. Acknowledging the importance of protein in cheese production, food scientists have worked with cheese makers to both identify and reduce the impact of A2 on cheese yield. Beyond yield impacts, Dr. Ibanez and his team of researchers at the Center for Dairy Research wanted to better understand specifically how proteolysis differs when casein proteins change and if this knowledge can ultimately be used to improve the human health impacts of cheese. Listen in to better understand how one slight change in amino acid sequence can transform the ripening process and ultimately the nutrients in your cheese. Topics of discussion 1:26      Introduction of Dr. Rodrigo Ibanez   2:32       Different proteins present in milk, based on genetics       4:00      How A2 milk impacts cheese making efficiency   5:52      Description of 4 types of casein in milk protein 8:07      Cheese yield losses with A2 milk ameliorated with skill of cheese makers. 9:46       Art of stirring the curd 10:30     Sire selection for A2, is it moving the mark?    12:10    Experimental design 12:50     How does A2 milk impact cheese quality – gel firmness and ripening 14:14    Protein and Fatty acid impact on flavor 15:50     Description of β-casomorphin peptides 19:11    A2 tend to be a little bit firmer then A1, and slower digestion.   20:20    Opioid activity in cheese 21:00     Testing for A2 protein fractions to confirm A2 milk was used for A2 cheese 22:42     Will aging help all cheeses be easier to digest? β-casomorphin 7 concentrations. 25:04    β-casomorphin impact on human health 26:54     What do you want ‘boots on the ground' dairymen to know about your project  Featured Articles: Comparison of the proteolysis and occurrence of a range of β-casomorphin peptides in commercial U.S. Cheddar cheeses manufactured from A1/A2 and A2/A2 β-casein milks #2xAg2030; #journalofdairyscience; #openaccess; #MODAIRY; #A2; #β-casomorphin; #casein; #A1; #ripening; #cheese; #whey; #DRMS; #dairysciencedigest; #ReaganBluel

Dopamine controls your motivation, focus, mood, and reward system — and most people are running low without realizing it. In this episode, Nurse Doza breaks down what dopamine actually does in the body, why deficiency is far more common than most people think, how your gut produces 50% of it, and the natural steps you can take to restore healthy levels. FEATURED PRODUCT: BLISS Bliss by MSW Nutrition is a lemon-flavored sublingual powder built around SAMe and TMG — two powerful methyl donors that directly support your body's natural dopamine and serotonin production through the methylation pathway. If you're feeling flat, foggy, or low-mood, methylation may be the missing link. One powder stick dissolved on your tongue — no water needed — and you may feel the difference within seconds to minutes. Bliss also supports glutathione production, liver health, and MTHFR function, making it one of the most targeted neurotransmitter support supplements available.

James Lasdun explores Murdaugh's claims of opioid addiction and a bizarre staged roadside shooting. He scrutinizes these events as attempts to distract from financial crimes or secure insurance payouts for survivors. (12/16)1920 SPARTANBURG SC

In this episode of RAPM Focus, RAPM's Social Media Editor, Alopi Patel, MD, engages with author and RAPM Associate Editor Dr. Sesh Mudumbai, MD, MS, and Oluwatobi Hunter, DNP, RN-BC, AGACNP-BC, following the December 2025 publication of their original research paper, “Utilization and opioid outcomes of a transitional pain service in high-risk surgical veterans: a cohort study.” Dr. Sesh Mudumbai is an associate professor of anesthesiology at Stanford University School of Medicine and director for clinical informatics systems and perioperative analytics at the VA Palo Alto Health Care System. His research focuses on understanding pain trajectories, opioid outcomes, and healthcare utilization patterns in surgical populations, with particular emphasis on developing data-driven and informatics-related approaches to improve perioperative care for high-risk veterans. He leads a research program at the intersection of clinical anesthesiology, pain medicine, and health services research.   Dr. Oluwatobi “Tobi” Hunter is the lead nurse practitioner for perioperative pain management and co-director of the transitional pain service at the Veterans Affairs Palo Alto Health Care System. Her clinical interests include perioperative pain management, contingency management for substance use disorders, buprenorphine initiation, auricular acupuncture, and building collaborative multidisciplinary teams. She engages in scholarship through peer-reviewed publications, webcasts, and speaking engagements. *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner's judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Podcast and music produced by Dan Langa. Find us on X @RAPMOnline, LinkedIn @Regional Anesthesia & Pain Medicine, Facebook @Regional Anesthesia & Pain Medicine, and Instagram @RAPM_Online.

In this episode, we speak with Victoria Barone, Assistant Professor at the University of Notre Dame, to discuss her recent NBER paper that examines the possible relationship between the opioid epidemic and the political realignment between the Republican and Democratic parties. While the public health consequences of the crisis are well-documented, Barone's research uncovers a startling political fallout. We explore how the rise in opioid-related deaths and addiction has altered voting patterns, shifted party leanings, and influenced electoral outcomes in the hardest-hit communities. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience in Permanent Supportive Housing JAMA Network Open This cohort study assessed 10,110 US veterans with homeless experience and opioid use disorder (OUD) residing in permanent supportive housing (PSH), in terms of what factors are associated with receipt of medications for opioid use disorder (MOUD).  Only 17% received MOUD within 12 months. Greater behavioral health engagement was associated with MOUD receipt, while older age, race minority status, and prior inpatient hospitalization were associated with lower odds. These results suggest that MOUD access in supportive housing should be expanding, which could require embedding addiction care into PSH teams, leveraging behavioral health touchpoints, and addressing persistent disparities.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Send us Fan Mail

In this weeks episode of cannabis news we cover the following stories: Macky: New research raises concerns about safety of higher-THC medicinal cannabis products in Australia  Smee: High Street mini-marts selling cocaine, cannabis and prescription drugs, BBC secret filming reveals  Dr.Margaret: RCMP disrupts multi-million dollar cannabis distribution network  Billy:   Cannabis MSOs sued in federal court over 'deceptive' medical marketing claims  John: More Older Adults Are Using Marijuana As An Alternative To Pharmaceuticals, Federally Funded Study From American Medical Association Shows We see more anti-cannabis propaganda this week, with a biased study coming out of Australia. We also find out about a concerning number of shops in the UK allegedly selling illegal drugs such as MDMA, meth, cocaine, and cannabis. Dr Margaret tells us about a huge cannabis bust where a multi-million-dollar trafficking network was shut down by the RCMP. Billy brings a story about a massive billion-dollar lawsuit being put together against cannabis firms for false advertising, and John tells us how older people are using more and more cannabis while relying less and less on opioids. Another packed episode with loads of interesting stories and discussions from around the world of cannabis! If you have any stories you would like us to cover on next weeks show, feel free to get in touch on any of your favourite networks! Thanks as always for listening, I hope you enjoy the show

Houston street hustler Jugg sits down with to tell the unbelievable story of how he helped fuel the hydrocodone pill explosion across Louisiana and Texas during the early opioid epidemic. From moving thousands of pills a week out of Houston pain clinics to watching entire communities fall into addiction, Jugg gives a raw firsthand account of the rise of “lean culture,” pill trafficking, doctor shopping, Roxy 30s, and the transition into today's fentanyl crisis. In this interview, Jugg breaks down: -How Houston pain clinics operated during the opioid boom -Making millions trafficking hydrocodone and Roxy pills -Drug culture in Houston and Louisiana in the 2000s -The rise of lean, syrup, and pill addiction -Corrupt clinics, pharmacies, and doctor shopping -Prison, street politics, and surviving the game -Why fentanyl changed everything -His life after prison running trucking businesses and podcasts This is one of the wildest untold stories from the Southern opioid epidemic — straight from someone who lived it. Go Support Jugg! IG: https://www.instagram.com/juggwdh YouTube: @wdhtv2 This Episode Is #Sponsored By Superpower! Head to https://superpower.com and use code CONNECT at checkout for $20 off your membership. Unlock your new health intelligence. 100+ biomarkers. Every year. Detect early signs of 1,000+ conditions. #superpowerpod Hims! To get simple, online access to personalized, affordable care for ED, Hair Loss, Weight Loss, and more, visit https://hims.com/connect Prescription required. See website for details and important safety information. Sildenafil is the generic version of Viagra®. Viagra® is a registered trademark of Viatris Specialty LLC. Hims is not affiliated with or endorsed by Viatris. Hell Fresh! Go to https://hellofresh.com/connect10fm now to Get 10 Free Meals + a Free breakfast for Life! One per box with active subscription. Free meals applied as discount on first box, new subscribers only, varies by plan. That's HelloFresh dot com slash connect10fm to Get 10 Free Meals + free breakfast for Life. Join The Patreon For Bonus Content! https://www.patreon.com/theconnectshow 00:00 Ground Floor of the Pill Game 01:45 Introducing Jugg: Origins & Early Hustle 03:30 Family Ties & Teenage Hustling 05:27 Crack, Pills & Generational Drug Shifts 08:17 The Houston Move & Pain Clinics 11:17 The Hydrocodone Boom 14:07 The Pill Market: Operations & Economics 19:07 Scaling Up: Distribution, Profits & Players 20:45 This Episode Is Sponsored By Superpower 232:29 From Weed to Pills: Business Evolution 28:07 Doctor Shopping & Law Enforcement Crackdown 29:56 This Episode Is Sponsored By Hims 31:38 Switching to Roxys & New Market Challenges 35:37 Effects on Community & Pill Culture 39:34 This Episode Is Sponsored By Hello Fresh 41:05 The Pharmacy System & Regulatory Changes 45:07 Crossing Over: Racial Lines & Generational Impact 48:57 Legal Troubles & Escalating Risks 53:07 Prison Time & Lessons Learned 01:00:17 Fake Pills & Fentanyl Danger 01:04:57 Rap Life vs. Hustle Life 01:10:47 Life after the Game: Trucking & Entrepreneurship 01:14:57 Logistics, Trucking, and Felon-Friendly Careers 01:19:17 Reflections, Community & Closing Thoughts Learn more about your ad choices. Visit podcastchoices.com/adchoices

The 4 p.m. "All Local" update for Thursday, May 7th, 2026.

People call methadone a life sentence, a ball and chain. Cato's Dr. Jeffrey Singer talks with Helen Redmond, author of "Liquid Handcuffs," about how a Nixon-era crime control program became America's dominant addiction treatment model, and why it needs to be abolished. Hosted on Acast. See acast.com/privacy for more information.

Live May 5, 2026 | Yaron Brook ShowStraits of Hormuz; AI regs; Opioids; Alberta; Germany; India; Ukraine; Pensions; Cancer | Yaron Brook Show#iranwar #abortion #Iran #PoliticalPhilosophy #CryptoDebate #WorldNews #Freedom #USPolitics #Capitalism #Objectivism #ForeignPolicyThe Yaron Brook Show is Sponsored by[The Ayn Rand Institute](https://www.aynrand.org/starthere)[Energy Talking Points, featuring AlexAI, by Alex Epstein](https://alexepstein.substack.com/)[Express VPN](https://www.expressvpn.com/yaron)[Hendershott Wealth Management](https://www.youtube.com/watch?v=X4lfC...) &(https://hendershottwealth.com/ybs/)[Michael Williams & The Defenders of Capitalism Project](https://www.DefendersOfCapitalism.com)[Support the Show]( / yaronbrookshow )[Sponsor the Show](askyaron@yaronbrookshow.com/)[One-time donation](https://bit.ly/2RZOyJJ)Join the [Yaron Brook Show YouTube channel]( / @yaronbrook )Like what you hear? Like, share, and subscribe to stay updated on new videos and help promote the [Yaron Brook Show](https://bit.ly/3ztPxTx)Continue the discussion by following Yaron on [Twitter](https://bit.ly/3iMGl6z) and [Facebook](https://bit.ly/3vvWDDC )Want to learn more about Ayn Rand and Objectivism? Visit the [Ayn Rand Institute](https://bit.ly/35qoEC3)Become a supporter of this podcast: https://www.spreaker.com/podcast/yaron-brook-show--3276901/support.Yaron is the executive chairman of the Ayn Rand Institute and a world class speaker. He is the coauthor of the national best-seller Free Market Revolution: How Ayn Rand's Ideas Can End Big Government, Equal is Unfair: America's Misguided Fight Against Income Inequality and In Pursuit of Wealth: The Moral Case for Finance. He speaks around the world on a variety of topics including the morality of capitalism, Ayn Rand and her philosophy, finance and economics, and the value of inequality.

How do you approach care management for opioid-addicted patients? Join the co-hosts for an honest conversation about opioid addiction stigma, recognizing withdrawal, and navigating treatment. Along the way, they share their own personal stories, struggles, and fresh insights to help you become a better med-surg nurse.   MEET OUR CO-HOSTS Kellye' McRae, MSN-Ed, RN is a dedicated Med-Surg Staff Nurse and Unit Based Educator based in South Georgia, with 12 years of invaluable nursing experience. She is passionate about mentoring new nurses, sharing her clinical wisdom to empower the next generation of nurses. Kellye' excels in bedside teaching, blending hands-on training with compassionate patient care to ensure both nurses and patients thrive. Her commitment to education and excellence makes her a cornerstone of her healthcare team.   Marcela Salcedo, RN, BSN is a Floatpool nightshift nurse in the Chicagoland area, specializing in step-down and medical-surgical care. A member of AMSN and the Hektoen Nurses, she combines her passion for nursing with the healing power of the arts and humanities. As a mother of four, Marcela is reigniting her passion for nursing by embracing the chaos of caregiving, fostering personal growth, and building meaningful connections that inspire her work. Hayley Sweetser, MSN, APRN, AGCNS-BC, MEDSURG-BC, CPHQ, WTA-C is a Clinical Nurse Specialist in Newark, Delaware who provides support to patients and caregivers within the Acute Medicine Service Line at ChristianaCare. She is working towards reducing overall patient harm events within the service line through collaboration with bedside nurses, physicians, and other specialties. Hayley has a strong passion for medical-surgical nursing and has spent her whole nursing career in this specialty. She strives to advance medical-surgical nursing practice by encouraging alignment with evidence-based practice.   Eric Torres, ADN, RN, CMSRN is a California native that has always dreamed of seeing the World, and when that didn't work out, he set his sights on nursing.  Eric is beyond excited to be joining the AMSN podcast and having a chance to share his stories and experiences of being a bedside medical-surgical nurse.   Sydney Wall, RN, BSN, CMSRN has been a med surg nurse for 5 years. After graduating from the University of Rhode Island in 2019, Sydney commissioned into the Navy and began her nursing career working on a cardiac/telemetry unit in Bethesda, Maryland.  Currently she is stationed overseas, providing care for service members and their families.  During her free time, she enjoys martial arts and traveling.  Trish West, DNP, MSN, CMSRN, PCCN, CEN, NEA-BC, FAMSN is a passionate nurse leader whose career reflects both expertise and a heartfelt commitment to advancing patient care. Trish's credentials include being a Certified Medical Surgical Registered Nurse, Progressive and Emergency Nursing, Nursing Executive Advanced, and most recently, induction as a Fellow in the Academy of Medical Surgical Nursing. She enjoys spending time with her husband Mark and their five children. Her favorite motto, "Never underestimate the difference you can make," truly captures the spirit with which Trish approaches both professional and personal endeavors.   

In this weeks cannabis news, we cover the following stories: Macky: Durham teen arrested in Malaysia for cannabis offences | The Northern Echo  Smee: Don't toss cannabis leaves: Scientists found rare compounds with medical potential | ScienceDaily Dr.Margaret: Cannabis users don't like pesticides: survey | the oz. Billy: Patients Choose Medical cannabis instead of opioids:   John: Trump administration move to reclassify cannabis sparks confusion  We take a look at the rescheduling of cannabis in the USA now John is back, getting his insight and finding out why things are a little confusing right now. We also cover a story from the UK about a 19-year-old locked up in Malaysia for possessing cannabis, who could face 30 years, or even the death penalty. Scary stuff. Margaret brings a story that seems pretty obvious… cannabis users don't like pesticides on their cannabis. Who knew?! Billy brings a story explaining how many people who suffer with pain prefer to use cannabis to help treat it instead of using opioids. We also talk about why you should keep your cannabis leaves, they have more uses than you might think. If you have any stories you would like us to cover on next weeks show, feel free to get in touch on any of your favourite networks! Thanks as always for listening, I hope you enjoy the show

In this episode, Maureen sits down with Dr. David Juurlink to explore one of the most complex issues in modern medicine: opioid prescribing. Together, they unpack the balance between benefit and harm, the realities of dependence, and the challenges clinicians face in managing chronic pain. This conversation dives into the evolving landscape of pain care—where safety, science, and patient experience don't always align—and offers a thoughtful, honest look at where we are today, and where we need to go next. The post Episode 81 : Dr. David Juurlink – Opioids, god's own medicine or the devil's brew? first appeared on Pain Talk.

Editor's Summary by Linda Brubaker, MD, Deputy Editor and Anne Cappola, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for articles published from April 25-May 1, 2026.

Three million Albertans discover the personal info they entrusted to provincial elections officials has wound up in the hands of a separatist group and Calgary professor Tom Keenan says that's a betrayal. In honour of his late brother, Toronto Blue Jays star Davis Schneider partners with the makers of Narcan — the nasal spray that can reverse an opioid overdose.The head of the UN's humanitarian agency Tom Fletcher says governments would rather spend on war than aid — even when there's more than enough money to help millions of people in need. Canada's Public Sector Integrity Commissioner tells us her office is worn down by a flood of complaints — and it needs more than a trickle of new funding. Jonathan Wilkinson will go from being a North Vancouver MP to Canada's new Ambassador to the EU. He gives us the diplomatic answer to a big question: should Canada join? A veteran war correspondent tells us that, nowadays, a press flak jacket puts a target on a journalist's back — and she's calling for independent investigations into the killings of reporters in war zones.Visitors flock to a San Francisco pier to see a local celebrity who's really throwing his weight around: the stout, unflappable, one-tonne sea lion known as "Chonkers." As It Happens, the Thursday edition. Radio that hopes the docks don't succumb to his pier pressure.

Show notes at pharmacyjoe.com/episode1125 In this episode, I’ll discuss an article about risk factors for serious and general opioid-related adverse drug events.

Send us Fan MailDr. Lori Devlin, neonatologist and principal investigator of the Optimize Now trial, shares results from the first multicenter randomized trial comparing symptom-based opioid dosing to scheduled opioid tapers in babies with neonatal opioid withdrawal syndrome (NOWS). Published in JAMA on the day of this recording, the trial found that symptom-based dosing reduced medical readiness for discharge by an additional 2.1 days — and that 65% of babies who would traditionally have been placed on a scheduled opioid taper never needed one at all. She also previews the next trial in this series, TREAT Now, which will compare buprenorphine versus morphine for babies who do require pharmacologic treatment, and reflects on how far the field has come since Eat Sleep Console first changed the way we think about caring for this population and their families.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Send us Fan MailDr. Ward Rice, neonatologist and researcher within the Neonatal Research Network, presents two-year follow-up data from the landmark ACT NOW Eat Sleep Console trial — one of the largest multi-center randomized trials ever conducted on neonatal opioid withdrawal syndrome. He shares findings on neurodevelopmental and behavioral outcomes at two years of age in babies exposed to buprenorphine versus methadone in utero, explaining why the short-term advantages of buprenorphine did not translate into measurable differences at this time point — but why both groups still scored below population norms on Bayley testing, underscoring the ongoing developmental risk in this population. He also discusses why longer follow-up is planned, what a smaller four-year study suggests may still emerge, and why this research ultimately informs prenatal decision-making by obstetric colleagues just as much as neonatal care at the bedside.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

#938. Ken Rideout has lived a lot of lives—and in this episode, he doesn't hold anything back. From being a full-blown opioid addict for over a decade while secretly building a high-powered Wall Street career… to becoming one of the fastest marathon runners in the world over 50—his story is as intense as it is inspiring.Ken opens up about growing up around addiction, the moment everything shifted after a simple ankle injury, and how he managed to hide it all—even from the people closest to him. He shares what it actually feels like to live a double life, the mental battle of getting sober, and the moment he knew he had to change everything before becoming a father.This is Part 1 of a two-part conversation… and trust me, you're going to want to come back Thursday for Part 2!If you're LOVING this podcast, please follow and leave a rating and review below! PLUS, FOLLOW OUR PODCAST INSTAGRAM HERE!Thank you to our Sponsors! Check out these AMAZING deals!Macy's: Go to macys.com, browse their gift guide, get inspired — and knock it out before Mother's Day sneaks up on you!Figs: Right now, if you go to wearFIGS.com and use the code FIGSRX, you can get 15% off your first order.EPISODE HIGHLIGHTS: (5:15) “One week is all it takes…” the brutal truth about how fast addiction takes over(17:15) It started with just 7 pills… how a simple injury turned into a 10-year addiction.(20:55) He hid his addiction while dating his wife—then she found him unconscious.(33:20) He'd never run an ultramarathon… then won a 155-mile race after just 1 month of training.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

About this episode: A collaboration between the Johns Hopkins Bloomberg School of Public Health, KFF Health News, and Shatterproof is tracking how communities across the country are spending opioid settlement funds. In this episode: Abigail Winiker of the Bloomberg Overdose Prevention Initiative details the good, bad, and the ugly of the expenditures the team has tracked, from EMS-delivered harm reduction methods to punitive law enforcement investments to... D.A.R.E magicians? Guest: Abigail Winiker, PhD, MSPH, is an assistant scientist at the Johns Hopkins Bloomberg School of Public Health and the program director of the Bloomberg Overdose Prevention Initiative. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Six Innovations in Settlement Fund Spending—Johns Hopkins Bloomberg School of Public Health Innovations in Opioid Settlement Fund Spending | CMAP Nexus Series—Health Policy and Management – BSPH via YouTube From Narcan to Gun Silencers, Opioid Settlement Cash Pays Law Enforcement Tabs—KFF Health News Edgecombe County honored for its innovative approach to opioid crisis—Rocky Mount Telegram Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Reagan Conrad speaks to Morning Wire on her investigation into the fast-growing kratom and 7-OH epidemic, a cheap gas-station drug that's quietly fueling addiction among thousands of Americans. Get the facts first with Morning Wire.- - -Ep. 2728- - -Wake up with new Morning Wire merch: https://bit.ly/4lIubt3- - -Today's Sponsors:ADF - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.Lean - Get 20% off when you enter code WIRE at https://TakeLean.com- - -Privacy Policy: https://www.dailywire.com/privacymorning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices